If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Journal of Nursing ScholarshipVolume 38 Issue 4, Pages 328 - 334 Published Online: 17 Nov 2006 © 2009 Sigma Theta Tau International Published with Sigma Theta Tau International, Honor Society of Nursing
Abstract | References | Full Text: HTML, PDF (Size: 208K) | Related Articles | Citation Tracking Genomics to Health Chronic Dementing Conditions, Genomics, and New Opportunities for Nursing Interventions Copyright 2006 Sigma Theta Tau International KEYWORDS
dementia
•
Alzheimer disease
•
Parkinson disease
•
genetics
•
gerontology
Journal of Nursing Scholarship, 2006; 38:4, 328-334. ©2006 Sigma Theta Tau International. ABSTRACTPurpose: To (a) provide an overview of chronic dementing conditions; (b) discuss the etiologic and clinical characteristics of Alzheimer disease (AD) and Parkinson disease (PD) within the framework of the family systems genetic illness model; and (c) to explore opportunities to enhance outcomes through the integration of genomics information and technologies into nursing practice. Design: An integrated review of the literature, including the organizing construct of the family systems genetic illness model. Findings: AD and PD are both influenced by genetic and environmental factors; in a small percentage of families, gene mutations are the primary etiologic factor. Genetic testing is an option for some families experiencing early-onset, familial disease. Presymptomatic and diagnostic genetic testing have limited clinical utility for the more common late-onset AD and PD. Conclusions: The current abilities of healthcare professionals to effectively intervene in people with AD and PD are limited by an incomplete understanding of the biologic basis of these diseases. Advances in genomics research and technology are providing the information and tools necessary to understand the molecular basis of these devastating disorders toward the goal of more specific and effective interventions. Accepted for publication July 11, 2006. |